How long is a drug patent going to last? This is a big question here today with Teva and Mylan being able to start marketing the generic version tomorrow. For us the patients, another big saver in the pharma area if you take Prevacid.
The difference in this case, the drug dissolves differently than the one that is or was under patent, actually the patent is still in place but not sure how much good it will do for Takeda right now with 2 generic companies ready to open the flood gates with the newer dissolving formula. 
Teva, from Israel has been pretty aggressive these days in court as there’s also the challenge with Merck and Singulair still ongoing. Why is all of this going on with patent challenges, pricing and maybe just because it can I think. BD
Nov. 10 (Bloomberg) -- Teva Pharmaceutical Industries Ltd. won a U.S. court ruling that may let it begin selling a generic version of Takeda Pharmaceutical Co.’s heartburn drug Prevacid SoluTab as soon as tomorrow.
Teva, the world’s largest generic-drug maker, said it would analyze the decision before deciding on its next step. U.S. District Judge Sue L. Robinson in Wilmington, Delaware, ruled yesterday that Teva’s version used a different way to dissolve the medicine than is covered by a patent owned by French drug researcher Ethypharm SA and licensed to Takeda.
Prevacid SoluTab is a dissolving tablet designed for people who have difficulty swallowing pills. The drug generated about $500 million in sales for Takeda during the 12 months ended June 30, Petah Tikva, Israel-based Teva said, citing data from market researcher IMS Health.
Mylan Inc. said its Matrix Laboratories unit also received final approval from the U.S. Food and Drug Administration and it too will begin immediate sales of Prevacid delayed-release capsules.
Takeda, based in Osaka, Japan, previously won a ruling that Teva’s plan to sell generic versions of Prevacid in the capsule and SoluTab forms infringed a different patent that expires today. The patent ruled on yesterday expires in 2013.
Teva Wins Ruling Over Copy of Takeda’s Prevacid Drug (Update2) - Bloomberg.com
0 comments :
Post a Comment